The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First results of the PROMPT trial: Precision oncology allocation in patients with early castration-resistant prostate cancer following routine molecular profiling.
 
Iris S. H. Kloots
No Relationships to Disclose
 
Peter H.J. Slootbeek
No Relationships to Disclose
 
Minke Smits
No Relationships to Disclose
 
Sjoerd van Helvert
Research Funding - Bayer (Inst)
 
Leonie I. Kroeze
No Relationships to Disclose
 
Marleen Kets
No Relationships to Disclose
 
Katrien Grünberg
Consulting or Advisory Role - Bristol Myers Squibb Foundation (Inst); Roche (Inst); Sakura Finetek Japan (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Illumina (Inst)
Travel, Accommodations, Expenses - MSD; Roche
 
Jolique van Ipenburg
No Relationships to Disclose
 
Marjolijn Ligtenberg
Employment - Synthon (I)
Honoraria - AstraZeneca (Inst); MSD (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
 
Jack A. Schalken
Honoraria - Bayer
Consulting or Advisory Role - MDxHealth
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; MDxHealth
 
Inge M. van Oort
No Relationships to Disclose
 
Haiko Bloemendal
No Relationships to Disclose
 
Winald R. Gerritsen
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); IMS Health (Inst); Janssen-Cilag (Inst); MSD (Inst); Sanofi (Inst)
Speakers' Bureau - ESMO (Inst); MSD (Inst)
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
 
Niven Mehra
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen-Cilag; MSD Oncology (Inst)
Research Funding - Astellas Pharma (Inst); Janssen-Cilag (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Janssen-Cilag; MSD Oncology; Roche